CD36 and neoplasm: Humanised CD36 antibodies, exemplified by clones 1G04 and Ona-0-v1, mirror the efficacy of JC63.1 and diminish tumour initiation and metastasis, particularly in liver and lung cancer models, by modulating lipid uptake [30].